There has been an explosion in the number of cancer therapeutics and clinical trials in the recent past, owing...
After three decades of failed efforts to target the elusive KRAS and its family members NRAS and HRAS, proto-oncogenes...
The AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held this year at the Hynes Convention Center in...
In recent decades, the cancer research community has made great strides by bringing new, targeted, safer, and longer-lasting treatments...
One of the world’s largest cancer research conferences, the AACR Annual Meeting 2019, came to an end with a...
About 80 percent of lung cancers are non-small cell lung cancers (NSCLC), and about 15 to 20 percent of...
Immune checkpoint inhibitors have become part of the standard of care for more than 14 different cancer types, including...
A pair of studies presented at the AACR Annual Meeting 2019 demonstrated encouraging clinical outcomes with two different chimeric...
The spectacular sight of the AACR Annual Meeting 2019 Opening Ceremony, held Sunday, March 31, at the Georgia World...
This year, the AACR Annual Meeting, the premier cancer research meeting in the world, is happening at the Georgia...